Pluxee (PLX) H2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2026 earnings summary
29 Oct, 2026Executive summary
FY26 exceeded financial objectives: revenue grew 0.7% organically, recurring EBITDA margin reached 37.5% with 101 bps of organic expansion, and recurring cash conversion was 70%; three-year average conversion was 82%.
Commercial momentum included €1.5bn in annualized new-client volumes, 99.4% net retention and 7.7% organic Employee Benefits volume growth.
FY27 is a transition year due to Brazil’s extended PAT reform rebase; medium-term plans target renewed profitable growth.
Financial highlights
FY26 revenue was €1,302m, up 0.7% organically and 1.2% reported; recurring EBITDA was €488m, up 3.8% organically and 3.7% reported.
Operating revenue was €1,136m, up 0.1% organically; float revenue was €166m, up 4.6%.
Net profit attributable to equity holders was €170m; adjusted net profit was €223m, up 1.2%, and adjusted basic EPS rose 4.4% to €1.58.
Recurring free cash flow was €341m versus €417m in FY25; FY25 benefited from favorable working-capital movements, particularly public-benefit volumes.
Operating profit was €295m; recurring EBIT was stable at €360m, while other operating expenses rose to €65m from €26m.
Outlook and guidance
FY27 targets at least €440m recurring EBITDA at constant FX and scope and at least 50% recurring cash conversion; revenue de-growth is expected during the transition year.
Brazil’s extended repricing scenario implies an estimated €110m incremental FY27 EBITDA headwind versus FY26, partly offset by business growth and efficiency measures.
The impact is expected to weigh more heavily in H1 FY27, with an H2 inflection; margins are expected slightly above H2 FY26 and revenue trends approaching stable.
Medium-term plans target profitable growth, steady organic recurring EBITDA margin expansion and normalized recurring cash conversion.
FY27 CapEx is expected at 8%–9% of revenue, focused on technology, data, AI and cybersecurity; cost base targeted broadly flat or slightly lower at constant currency.
Latest events from Pluxee
- Nine-month revenue up +2.7% organically; Brazil reform to weigh more heavily in Q4.PLX
Q3 2026 TU - Strong H1 FY26 growth and margin expansion, led by Employee Benefits, despite Brazil risks.PLX
H1 2026 - Q1 organic revenue up 9% to EUR 308m, led by Employee Benefits and strong Latin America growth.PLX
Q1 2026 TU - Double-digit organic growth, margin expansion, and strong cash flow drive upgraded outlook.PLX
H2 2025 - Q3 organic revenue grew 11.1% to €310M, with guidance reaffirmed and strong Latin America momentum.PLX
Q3 2025 TU - Record growth, sharply higher dividend, and all AGM resolutions approved.PLX
AGM 2024 - Record 2024 results with 18.6% organic growth, strong cash flow, and upgraded outlook.PLX
H2 2024 - Q3 organic revenue up 17.9%, FY2024 growth target raised to ~18% on strong global momentum.PLX
Q3 2024 TU - Double-digit organic growth, margin upgrade, and strong cash flow drive robust H1 results.PLX
H1 2025